Reference |
- 1. Grutter MG (2000). Caspases: key players in programmed cell death. Curr Opin Struct Biol 10, 649-55;
- 2. Gastman BR (2001). Apoptosis and its clinical impact. Head Neck 23, 409-25;
- 3. Grutter MG (2000). Caspases: key players in programmed cell death. Curr Opin Struct Biol 10, 649-55;
- 4. Stennicke HR and Salvesen GS (1999). Catalytic properties of the caspases. Cell Death Differ 6, 1054-9;
- 5. Stennicke HR and Salvesen GS (1998). Properties of the caspases. Biochim Biophys Acta 1387, 17-31;
- 6. Thornberry NA and Lazebnik Y (1998). Caspases: enemies within. Science 281, 1312-6;
- 7. Talanian RV, et al. (1997). Substrate specificities of caspase family proteases. J Biol Chem 272, 9677-82;
- 8. Fassy F, et al. (1998). Enzymatic activity of two caspases related to interleukin-1beta-converting enzyme. Eur J Biochem 253, 76-83; 9. Datta R, et al. (1996). Activation of the CPP32 protease in apoptosis induced by 1-?-D-arabinofuranosylcytosine and other DNA-damaging agents. Blood 88, 1936-43;
- 10. Koeplinger KA, et al. (2000). Caspase 8: an efficient method for large-scale autoactivation of recombinant procaspase 8 by matrix adsorption and characterization of the active enzyme. Protein Expr Purif 18, 378-87.
|